Carboplatin
2 NDCs across 2 manufacturers|2 Generic,0 Brand
Carboplatin is used to treat bone marrow diseases, breast neoplasms, central nervous system neoplasms, endometrial neoplasms, esophageal neoplasms and lung neoplasms, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Mar 3, 1989, and the first generic was approved Oct 14, 2004. In 2024, Medicare Part D spent $186K on Carboplatin across 3,489 claims for 1,037 beneficiaries.
Carboplatin is available as 2 NDCs from 2 manufacturers (2 generic, 0 brand), with NADAC prices from $0.99 to $0.99 per ML. Every pack size and labeler in this drug market is compared side-by-side below.
Active FDA drug shortage
29 Carboplatin presentations are currently listed in FDA's drug shortage database (first posted Apr 28, 2023). Shortages can move NADAC prices in the following weeks.
Total NDCs
2
2G / 0B
Manufacturers
2
competing in market
Price Spread
$0.99 – $0.99
per ML
7d Activity
avg +0.0% WoW · of 2 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
2 manufacturers producing CARBOPLATIN
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
CARBOPLATIN 150 MG/15 ML VIAL | $0.9933 per ML | — |
CARBOPLATIN 150 MG/15 ML VIAL | $0.9933 per ML | — |
Frequently Asked Questions
What is Carboplatin used to treat?
Carboplatin is used to treat bone marrow diseases, breast neoplasms, central nervous system neoplasms, endometrial neoplasms, esophageal neoplasms and lung neoplasms, per the National Library of Medicine's MED-RT classification.
When did Carboplatin become available as a generic?
FDA approved the first generic Carboplatin (ANDA) on Oct 14, 2004.
How much does Medicare spend on Carboplatin?
In 2024, Medicare Part D spent $186K on Carboplatin across 3,489 claims for 1,037 beneficiaries.
Is Carboplatin in shortage?
Yes — FDA's drug shortage database currently lists 29 Carboplatin presentations with status "Current", first posted Apr 28, 2023.
How many Carboplatin products are on the market?
The Carboplatin drug market contains 2 NDCs from 2 manufacturers — 2 generic and 0 brand products.
What is the price range for Carboplatin?
NADAC reference prices for Carboplatin range from $0.9933 to $0.9933 per ML.
Which manufacturers make Carboplatin?
2 manufacturers list Carboplatin in NADAC. Ranked by number of NDCs, the largest are Hospira Inc. (1), Teva Parenteral Medicines, Inc. (1).